Skip to main content

Podcast

Difficult-to-treat Rheumatoid Arthritis Validation of the EULAR Definition

Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria.

DMARDs and Herpes Zoster Vaccination To Stop or Not To Stop

Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.

Does Withdrawing Steroids Increase Flares?

Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria.

We've Got To Talk About CAR T Cells

Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.

EULAR 2024 Daily Podcasts Day1&2

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr.

Predicting Palindromic Prognosis

Dr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria.

A Step Closer to Identifying Phenotypes of RA ILD

Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Pain in RA: Different Drugs for Different Mechanisms

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

Giant Cell Arteritis and Polymyalgia Rheumatica Update

Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.

JAK Inhibitors For New Indications

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
×